CCRF-CEM/iRFP stable cell line

CCRF-CEM/iRFP cells are derived from the human CCRF-CEM T lymphoblast cell line by stably integration of a constitutive miRFP670 stably expression construct. CCRF-CEM cell line was generated from acute lymphoblastic leukemia, has been widely used for investigating the mechanisms underlying leukemia development, progression, and drug resistance. Additionally, these cells are often employed in screening assays to evaluate the efficacy and toxicity of potential anti-leukemic drugs. CCRF-CEM/iRFP cells stably stably express miRFP670, can be used for in vitro assays and in vivo imaging.